Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
In this episode of MesoTV, we are joined by Suellen Crano, a 21-year peritoneal mesothelioma survivor, who shares her story from the early stages of
This week, Nature Medicine published the results, as well the genomic and immunologic analyses, from the Phase 2 PrE0505 clinical trial. The trial, which took
We sit down with Chuong D. Hoang, MD, thoracic surgical oncologist at the National Cancer Institute to discuss his new hydrogel based therapy for mesothelioma.
Dear friends and supporters, We are delighted to report that the Meso Foundation has selected a Patient Services Director to succeed Mary Hesdorffer, who is
Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many friends of the Mesothelioma Applied Research Foundation, we are pleased
Jessica Blackford-Cleeton and Rich Mosca, both members of the mesothelioma community, recently participated in the evaluation of research proposals for funding through the Congressionally Directed
This is a panel of mesothelioma patients and caregivers about managing costs associated with travel to mesothelioma specialists and clinical trials for treatment. Moderated by
Today, Bristol Myers Squibb announced new three-year overall survival data from its CheckMate -743 study. These data are based on the clinical trial of nivolumab/ipilimumab